Sign In
Buy NDRA
$4.73
-0.310 (-6.15%)
At Close: Jun 03, 2026
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
08:00am, Tuesday, 07'th May 2024
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will r
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
08:00am, Thursday, 02'nd May 2024
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of five new patents, inc
ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
09:10pm, Thursday, 28'th Mar 2024
ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
04:05pm, Thursday, 28'th Mar 2024
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three m
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
08:00am, Thursday, 21'st Mar 2024
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will r
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
08:30am, Wednesday, 14'th Feb 2024
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new patents, in
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
08:00am, Wednesday, 29'th Nov 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Tra
ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference
08:00am, Monday, 27'th Nov 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will be participating
ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript
10:14pm, Tuesday, 14'th Nov 2023
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2023 Results Conference Call November 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
04:05pm, Tuesday, 14'th Nov 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three a
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
04:05pm, Tuesday, 07'th Nov 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will r
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023
08:00am, Monday, 06'th Nov 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced it will host an offsite panel d
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
08:00am, Thursday, 07'th Sep 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a clinical ab
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
08:00am, Wednesday, 30'th Aug 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the Com
ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
08:00am, Wednesday, 23'rd Aug 2023
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new patents, on
